We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$287B
AUM Growth
+$18.5B
Cap. Flow
-$4.92B
Cap. Flow %
-1.71%
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$672M
2
AMAT icon
Applied Materials
AMAT
+$241M
3
KVUE icon
Kenvue
KVUE
+$220M
4
CRM icon
Salesforce
CRM
+$210M
5
PYPL icon
PayPal
PYPL
+$195M

Sector Composition

Rank Sector Weight
1 Technology 27.88%
2 Healthcare 12.64%
3 Financials 11.25%
4 Consumer Discretionary 11%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPK icon
1726
Chesapeake Utilities
CPK
$3.21B
$6.78M ﹤0.01%
56,972
-96
-0.2% -$12.1K
CNR
1727
Core Natural Resources Inc
CNR
$4.45B
$6.78M ﹤0.01%
99,932
+795
+0.8% +$48.5K
PTEN icon
1728
Patterson-UTI
PTEN
$3.76B
$6.78M ﹤0.01%
566,103
-660
-0.1% -$7.45K
AMED
1729
DELISTED
Amedisys
AMED
$6.77M ﹤0.01%
74,046
-319
-0.4% -$26.2K
LGF.B
1730
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$6.74M ﹤0.01%
806,992
+362,016
+81% +$3.56M
TNC icon
1731
Tennant Co
TNC
$1.26B
$6.71M ﹤0.01%
82,751
+32,030
+63% +$2.41M
NWS icon
1732
News Corp Class B
NWS
$17.5B
$6.7M ﹤0.01%
339,944
-7,380
-2% -$135K
DNA icon
1733
Ginkgo Bioworks
DNA
$521M
$6.68M ﹤0.01%
89,742
+16,933
+23% +$1M
NRIX icon
1734
Nurix Therapeutics
NRIX
$2.65B
$6.67M ﹤0.01%
667,417
-2,556
-0.4% -$26.1K
AZZ icon
1735
AZZ Inc
AZZ
$4.54B
$6.65M ﹤0.01%
152,900
-11,863
-7% -$456K
BHF icon
1736
Brighthouse Financial
BHF
$3.5B
$6.62M ﹤0.01%
139,871
-629
-0.4% -$27.1K
PJT icon
1737
PJT Partners
PJT
$4.38B
$6.62M ﹤0.01%
95,085
+1,972
+2% +$136K
MSEX icon
1738
Middlesex Water
MSEX
$1.1B
$6.62M ﹤0.01%
82,084
+32,208
+65% +$2.52M
BF.A icon
1739
Brown-Forman Class A
BF.A
$13.3B
$6.61M ﹤0.01%
97,155
-4,562
-4% -$297K
ENVX icon
1740
Enovix
ENVX
$1.03B
$6.58M ﹤0.01%
417,062
+79,681
+24% +$927K
IPAR icon
1741
Interparfums
IPAR
$3.94B
$6.56M ﹤0.01%
48,493
-2,874
-6% -$403K
PTON icon
1742
Peloton Interactive
PTON
$2.49B
$6.55M ﹤0.01%
852,063
+11,660
+1% +$99.1K
CCS icon
1743
Century Communities
CCS
$2.03B
$6.53M ﹤0.01%
85,217
-417
-0.5% -$27.9K
NUS icon
1744
Nu Skin
NUS
$267M
$6.52M ﹤0.01%
196,511
+29,622
+18% +$1.09M
PEB icon
1745
Pebblebrook Hotel Trust
PEB
$2.05B
$6.52M ﹤0.01%
467,958
+60,259
+15% +$840K
BHE icon
1746
Benchmark Electronics
BHE
$2.96B
$6.48M ﹤0.01%
250,981
ECHO
1747
EchoStar
ECHO
$26.2B
$6.47M ﹤0.01%
373,167
-1,637
-0.4% -$27.6K
XPRO icon
1748
Expro Ltd
XPRO
$1.91B
$6.45M ﹤0.01%
364,139
+34,732
+11% +$627K
NGVT icon
1749
Ingevity
NGVT
$2.68B
$6.45M ﹤0.01%
110,923
-207,183
-65% -$12.4M
CTRE icon
1750
CareTrust REIT
CTRE
$9.74B
$6.44M ﹤0.01%
324,326
+1,705
+0.5% +$33.3K

Similar funds

Nuveen's Q2 2023 Portfolio in Review

As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
  • Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
  • Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
  • Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
  • Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
  • Nuveen opened 280 new positions and closed 179 in Q2 2023.
  • Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.